Adult Patients with Primary Malignant Brain Tumor and Admission to the Intensive Care Unit

被引:1
作者
Alentorn, A. [1 ,2 ,3 ,4 ,5 ]
Weiss, N. [6 ,7 ]
Delattre, J. Y. [1 ,2 ,3 ,4 ,5 ]
Idbaih, A. [1 ,2 ,3 ,4 ,5 ]
机构
[1] Grp Hosp Pitie Salpetriere, AP HP, Serv Neurol, 2 Mazarin, Paris, France
[2] UPMC Univ Paris 06, Sorbonne Univ, ICM, UM 75, F-75013 Paris, France
[3] INSERM, ICM Paris, U 1127, F-75013 Paris, France
[4] CNRS, ICM Paris, UMR 7225, F-75013 Paris, France
[5] ICM, F-75013 Paris, France
[6] Grp Hosp Pitie Salpetriere, AP HP, Unite Reanimat Neurol Federat Neurol 1, Pole Malad Syst Nerveux, F-75013 Paris, France
[7] IHU A ICM, Inst Neurosci Translat, Paris, France
来源
REANIMATION | 2015年 / 24卷 / 04期
关键词
Brain tumor; Neuro-oncology; Intensive care unit; Glioblastoma; Brain lymphoma;
D O I
10.1007/s13546-015-1073-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent therapeutic advances have allowed improving prognosis and quality of life of adult patients suffering from malignant primary brain tumors (MPBT), sometimes after a transient medical support in the intensive care unit (ICU). Indeed, patients with MPBT may have, during the course of their neuro-oncological disease, organ failure(s) due to: (i) a destabilization of pre-existing chronic conditions; (ii) an acute pathology unrelated to MPBT; (iii) a complication of MPBT; and/or (iv) complications induced by anti-tumor treatments. The short-term and the long-term benefits of an ICU stay for patients with MPBT are not clearly documented in the literature. A dedicated study, including recent advances in the field of MPBT, would participate to remove the historical brake associated with admission of MPBT patients in ICU. Due to the lack of medical and scientific evidences, admission of MPBT patients in ICU requires a multidisciplinary discussion between the neuro-oncologist, the intensivist, the relatives of the patient and the family of the patient. This discussion will also incorporate patient's advanced directives registered during the first visit, the prognosis and the therapeutic perspectives of the MPBT and the acute affection. Further prospective clinical studies will modulate with higher level of evidence these recommendations.
引用
收藏
页码:424 / 432
页数:9
相关论文
共 52 条
[41]   Pilomyxoid Astrocytoma Treated Successfully With Vemurafenib [J].
Skrypek, Mary ;
Foreman, Nicholas ;
Guillaume, Daniel ;
Moertel, Christopher .
PEDIATRIC BLOOD & CANCER, 2014, 61 (11) :2099-2100
[42]   Short- and long-term outcomes of critically ill patients with cancer and prolonged ICU length of stay [J].
Soares, Marcio ;
Salluh, Jorge I. F. ;
Torres, Viviane B. L. ;
Leal, Juliana V. R. ;
Spector, Nelson .
CHEST, 2008, 134 (03) :520-526
[43]   Guidelines on management of low-grade gliomas: report of an EFNS-EANO* Task Force [J].
Soffietti, R. ;
Baumert, B. G. ;
Bello, L. ;
von Deimling, A. ;
Duffau, H. ;
Frenay, M. ;
Grisold, W. ;
Grant, R. ;
Graus, F. ;
Hoang-Xuan, K. ;
Klein, M. ;
Melin, B. ;
Rees, J. ;
Siegal, T. ;
Smits, A. ;
Stupp, R. ;
Wick, W. .
EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (09) :1124-1133
[44]   Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma [J].
Stupp, R ;
Mason, WP ;
van den Bent, MJ ;
Weller, M ;
Fisher, B ;
Taphoorn, MJB ;
Belanger, K ;
Brandes, AA ;
Marosi, C ;
Bogdahn, U ;
Curschmann, J ;
Janzer, RC ;
Ludwin, SK ;
Gorlia, T ;
Allgeier, A ;
Lacombe, D ;
Cairncross, JG ;
Eisenhauer, E ;
Mirimanoff, RO ;
Van Den Weyngaert, D ;
Kaendler, S ;
Krauseneck, P ;
Vinolas, N ;
Villa, S ;
Wurm, RE ;
Maillot, MHB ;
Spagnolli, F ;
Kantor, G ;
Malhaire, JP ;
Renard, L ;
De Witte, O ;
Scandolaro, L ;
Vecht, CJ ;
Maingon, P ;
Lutterbach, J ;
Kobierska, A ;
Bolla, M ;
Souchon, R ;
Mitine, C ;
Tzuk-Shina, T ;
Kuten, A ;
Haferkamp, G ;
de Greve, J ;
Priou, F ;
Menten, J ;
Rutten, I ;
Clavere, P ;
Malmstrom, A ;
Jancar, B ;
Newlands, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (10) :987-996
[45]   Anaplastic astrocytoma in adults [J].
Stupp, Roger ;
Reni, Michele ;
Gatta, Gemma ;
Mazza, Elena ;
Vecht, Charles .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 63 (01) :72-80
[46]   Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial [J].
Stupp, Roger ;
Hegi, Monika E. ;
Mason, Warren P. ;
van den Bent, Martin J. ;
Taphoorn, Martin J. B. ;
Janzer, Robert C. ;
Ludwin, Samuel K. ;
Allgeier, Anouk ;
Fisher, Barbara ;
Belanger, Karl ;
Hau, Peter ;
Brandes, Alba A. ;
Gijtenbeek, Johanna ;
Marosi, Christine ;
Vecht, Charles J. ;
Mokhtari, Karima ;
Wesseling, Pieter ;
Villa, Salvador ;
Eisenhauer, Elizabeth ;
Gorlia, Thierry ;
Weller, Michael ;
Lacombe, Denis ;
Cairncross, J. Gregory ;
Mirimanoff, Rene-Olivier .
LANCET ONCOLOGY, 2009, 10 (05) :459-466
[47]   Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial [J].
Taal, Walter ;
Oosterkamp, Hendrika M. ;
Walenkamp, Annemiek M. E. ;
Dubbink, Hendrikus J. ;
Beerepoot, Laurens V. ;
Hanse, Monique C. J. ;
Buter, Jan ;
Honkoop, Aafke H. ;
Boerman, Dolf ;
de Vos, Filip Y. F. ;
Dinjens, Winand N. M. ;
Enting, Roelien H. ;
Taphoorn, Martin J. B. ;
van den Berkmortel, Franchette W. P. J. ;
Jansen, Rob L. H. ;
Brandsma, Dieta ;
Bromberg, Jacoline E. C. ;
van Heuvel, Irene ;
Vernhout, Rene M. ;
van der Holt, Bronno ;
van den Bent, Martin J. .
LANCET ONCOLOGY, 2014, 15 (09) :943-953
[48]   Predictive biomarkers investigated in glioblastoma [J].
Tabouret, Emeline ;
Chinot, Olivier ;
Sanson, Marc ;
Loundou, Anderson ;
Hoang-Xuan, Khe ;
Delattre, Jean-Yves ;
Idbaih, Ahmed .
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2014, 14 (07) :883-893
[49]   Characteristics and outcomes of cancer patients in European ICUs [J].
Taccone, Fabio Silvio ;
Artigas, Antonio A. ;
Sprung, Charles L. ;
Moreno, Rui ;
Sakr, Yasser ;
Vincent, Jean-Louis .
CRITICAL CARE, 2009, 13 (01)
[50]   Outcome of cancer patients considered for intensive care unit admission:: A hospital-wide prospective study [J].
Thiéry, G ;
Azoulay, P ;
Darmon, M ;
Ciroldi, M ;
De Miranda, S ;
Lévy, V ;
Fieux, F ;
Moreau, D ;
Le Gall, JR ;
Schlemmer, B .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (19) :4406-4413